“The value our digital health solutions provide to patients, clinicians and healthcare systems is unique, and this cluster of data supporting what we’ve established validates that our technology improves outcomes,” said Bajaj. “We intend to focus our innovation on solutions that will succeed in the changing market and reduce costs to value-based healthcare systems.”
KCI presented more than 25 abstracts and two oral presentations at the SAWC Spring conference, showcasing substantial clinical evidence supporting a full range of wound management products. Together, this bolus of evidence underscores the unsurpassed clinical and economic value of the Acelity portfolio of wound care solutions.
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About iOn PROGRESS™ Remote Therapy Monitoring
iOn PROGRESS™ Remote Therapy Monitoring is the first system to deliver continuous at-home monitoring for patients prescribed NPWT in the home. It works in conjunction with the ACTIV.A.C.™ System to monitor adherence and securely transmit data to the KCI iOn PROGRESS™ Care Network, a group of highly-trained individuals who interact with patients to drive proper utilization.
About KCI, an Acelity Company
KCI, an Acelity Company, the most trusted brand in advanced wound care, is committed to developing innovative healing solutions for customers and patients across the care continuum. Our unsurpassed product portfolio is available in more than 90 countries and delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Committed to advancing the science of healing, KCI sets the standard for leading advanced wound therapy innovation. Headquartered in San Antonio, Texas, KCI employs nearly 5,000 people around the world.
Back to HCB News
